On Sunday, U.S. President Donald Trump changed that precedent, announcing that he would sign an executive order Monday to ...

Shares of major U.S. drugmakers Eli Lilly, Pfizer, Merck, AbbVie and Amgen fell between 2% and 4% in premarket trading Monday ...

Gov. Laura Kelly and Merck Animal Health — a veterinary medicine company — announced an $895 million expansion project at the ...

Merck (MRK) invests $895M to expand a Kansas facility in a bid to boost production of vaccine and other biologic in its ...

To keep up with growing demand, ​​Merck Animal Health will invest nearly $900 million to expand its manufacturing facility in ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

The Delaware facility will ensure a domestic supply of biologic drugs including the cancer drug Keytruda.

The firm reported revenues of $15.53 billion and adjusted earnings per share of $2.22, surpassing consensus predictions of ...

Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...

About two months after receiving a sizable taxpayer-funded grant, Merck & Co. officially announced it would build its newest ...

A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D ...

She regularly appears on CBS News 24/7 to discuss her reporting. Merck is investing $1 billion to build a U.S. plant in ...